Table 3 Proportion of respondents with clinically important problems in QLQ-C30 subscales before and during the COVID-19 pandemic
From: Functional health and symptoms in Spain before and during the COVID-19 pandemic
|  | Before COVID-19 pandemic (N = 1010) | During COVID-19 pandemic (N = 504) | Comparison | |
|---|---|---|---|---|
Chi-square | p-value | |||
Physical functioning | 17.6% | 17.9% | 0.02 | 0.911 |
Role functioning | 5.0% | 11.1% ↑ | 19.60 | < 0.001 |
Emotional functioning | 33.7% | 40.9% ↑ | 7.58 | 0.006 |
Cognitive functioning | 15.1% | 13.7% | 0.57 | 0.450 |
Fatigue | 16.7% | 14.1% | 1.76 | 0.184 |
Nausea and vomiting | 13.0% | 14.7% | 0.84 | 0.359 |
Pain | 39.6% | 32.9% ↓ | 6.38 | 0.012 |
Dyspnea | 25.3% | 19.8% ↓ | 5.67 | 0.017 |
Sleep disturbances | 16.3% | 18.8% | 1.49 | 0.222 |
Appetite loss | 5.7% | 4.0% | 2.17 | 0.141 |
Constipation | 6.9% | 6.3% | 0.18 | 0.761 |
Diarrhea | 18.6% | 9.6% | 0.23 | 0.630 |